News Home

Should You Buy BioNano Genomics Inc (BNGO) Stock Thursday Morning?

Thursday, August 11, 2022 08:54 AM | InvestorsObserver Analysts
Should You Buy BioNano Genomics Inc (BNGO) Stock Thursday Morning?

BioNano Genomics Inc (BNGO) is down Thursday morning, with the stock declining -1.33% in pre-market trading to 2.96. BNGO's short-term technical score of 71 indicates that the stock has traded more bullishly over the last month than 71% of stocks on the market. In the Diagnostics & Research industry, which ranks 127 out of 146 industries, BioNano Genomics Inc ranks higher than 84% of stocks. BioNano Genomics Inc has risen 98.68% over the past month, closing at $1.51 on July 14. During this period of time, the stock fell as low as $1.51 and as high as $3.00. BNGO has an average analyst recommendation of Strong Buy. The company has an average price target of $8.25.

Overall Score - 74
BNGO has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on BNGO!
BioNano Genomics Inc has a Long-Term Technical rank of 77. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 23% of the market scoring higher. In the Diagnostics & Research industry which is number 78 by this metric, BNGO ranks better than 78% of stocks.

Important Dates for Investors in BNGO:

-BioNano Genomics Inc is set to release earnings on 11/2/2022. Over the last 12 months, the company has reported EPS of $-0.37. -We do not have a set dividend date for BioNano Genomics Inc at this time. Click Here To Get The Full Report on BioNano Genomics Inc (BNGO)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App